HomeGEECEE › Filing
🔔 Get instant alerts when GEECEE files quarterly results on BSE Start free trial →

In continuation to our letter dated July 31, 2026, we wish to inform you that the Board of Directors of the Company at its meeting held on Thursday, August 06, 2026 has inter-alia considered ....

Filed: 06 Aug 2026, 18:21 IST Exchange: BSE Category: Financial Results — Audited Results
Q1FY27 results (unaudited): Standalone: Revenue 11.0bn (7.2bn) PAT 4.8bn (3.9bn) Consolidated: Revenue 37.5bn (7.6bn) PAT 8.4bn (5.1bn) Dividend: Rs 10/share (record date Monday, September 07, 2026) Commentary: The Company recognized a gain of 0.96bn as an exceptional item on loss of control of a subsidiary which became an associate from June 30, 2026.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 GEECEE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add GEECEE to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on GeeCee Ventures Limited

Important. The summary above is generated automatically from GeeCee Ventures Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.